OXALIPLATINE ARROW LAB 5 mg/mL

DRUG3 trials

Sponsors

Institut De Cancerologie De L Ouest, Institut Regional Du Cancer De Montpellier, Unicancer

Conditions

Patients with newly diagnosed advanced peritoneal metastasis from colorectal cancerStage III colorectal cancerlocal advenced pancreatic adenocarcinoma

Phase 2

PHASE II study evaluating the benefit of Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

RecruitingCTIS2024-515344-23-00

Institut Regional Du Cancer De Montpellierlocal advenced pancreatic adenocarcinoma

Start: 2021-06-17Target: 103Updated: 2025-03-24

Systemic antitumor treatment with or without pressurized intraperitoneal aerosol chemotherapy (PIPAC) for colon peritoneal metastases – a multicentre phase II randomized trial (PIPOX02)

RecruitingCTIS2024-514560-10-00

Institut De Cancerologie De L OuestPatients with newly diagnosed advanced peritoneal metastasis from colorectal cancer

Start: 2025-06-12Target: 114Updated: 2024-10-11

Phase 3

CIRCULATE III - Tailoring the decision for adjuvant chemotherapy using circulating tumour DNA, in patients with stage III colorectal cancer

Not yet recruitingCTIS2025-521045-24-00

UnicancerStage III colorectal cancer

Target: 240Updated: 2026-04-28